Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Enterprise Value (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Enterprise Value for 16 consecutive years, with -$10.6 million as the latest value for Q3 2025.

  • Quarterly Enterprise Value fell 50.17% to -$10.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$10.6 million through Sep 2025, down 50.17% year-over-year, with the annual reading at -$6.2 million for FY2024, 5.03% down from the prior year.
  • Enterprise Value for Q3 2025 was -$10.6 million at Xtant Medical Holdings, down from -$7.0 million in the prior quarter.
  • The five-year high for Enterprise Value was -$4.4 million in Q2 2023, with the low at -$20.5 million in Q2 2021.
  • Average Enterprise Value over 5 years is -$11.5 million, with a median of -$8.7 million recorded in 2023.
  • The sharpest move saw Enterprise Value crashed 685.43% in 2021, then skyrocketed 73.6% in 2023.
  • Over 5 years, Enterprise Value stood at -$18.4 million in 2021, then dropped by 11.53% to -$20.5 million in 2022, then skyrocketed by 71.12% to -$5.9 million in 2023, then fell by 5.03% to -$6.2 million in 2024, then plummeted by 71.05% to -$10.6 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$10.6 million, -$7.0 million, and -$5.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.